Influence of parstatin on experimental periodontal disease and repair in rats

Journal of Periodontology

Volumn 85, Issue 9, 2014, Pages 1266-1274

  Spolidorio, Luís Carlos ^a   Lucas, Pablo Dallari Ramalho ^a   Steffens, Joao Paulo ^a   Da Silva, Henrique Aparecido Bueno ^b   Alves, Vanessa Tubero Euzebio ^b   Spolidorio, Denise M Palomari ^a   Holzhausen, Marinella ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Human; Inflammation; Neovascularization; PAR 1 receptor (1 41); Periodontal diseases; Physiologic; Rats; Wound healing

Indexed keywords

ANGIOGENESIS INHIBITOR; COLLAGEN; ENDOSTATIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; PEPTIDE FRAGMENT; PEROXIDASE; PROTEINASE ACTIVATED RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ALVEOLAR BONE LOSS; ANIMAL; BLOOD VESSEL; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; GINGIVA; JAW; MACROPHAGE; MALE; MICRO-COMPUTED TOMOGRAPHY; PATHOPHYSIOLOGY; PERIODONTITIS; PROCEDURES; RAT; SPRAGUE DAWLEY RAT; TIME; WOUND HEALING;

ALVEOLAR BONE LOSS; ALVEOLAR PROCESS; ANGIOGENESIS INHIBITORS; ANIMALS; BLOOD VESSELS; COLLAGEN; DISEASE MODELS, ANIMAL; ENDOSTATINS; GINGIVA; INTERLEUKIN-1BETA; INTERLEUKIN-6; MACROPHAGES; MALE; PEPTIDE FRAGMENTS; PERIODONTITIS; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, PAR-1; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING; X-RAY MICROTOMOGRAPHY;

EID: 84914150614     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2014.130619     Document Type: Article

References (30)

1. Ossovskaya VS, Bunnett NW. Protease-activated receptors: Contribution to physiology and disease. Physiol Rev 2004;84:579-621.
2. Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, Kuliopulos A. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 2005;120:303-313.
3. Uehara A, Muramoto K, Imamura T, et al. Argininespecific gingipains from Porphyromonas gingivalis stimulate production of hepatocyte growth factor (scatter factor) through protease-activated receptors in human gingival fibroblasts in culture. J Immunol 2005;175:6076-6084.
4. Austin KM, Covic L, Kuliopulos A. Matrix metalloproteases and PAR1 activation. Blood 2013;121: 431-439.
5. Strande JL, Widlansky ME, Tsopanoglou NE, et al. Parstatin: A cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury. Cardiovasc Res 2009;83:325-334.
6. Zania P, Gourni D, Aplin AC, et al. Parstatin, the cleaved peptide on proteinase-activated receptor 1 activation, is a potent inhibitor of angiogenesis. J Pharmacol Exp Ther 2009;328:378-389.
7. Huang H, Vasilakis P, Zhong X, et al. Parstatin suppresses ocular neovascularization and inflammation. Invest Ophthalmol Vis Sci 2010;51:5825-5832.
8. Lourbakos A, Potempa J, Travis J, et al. Argininespecific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect Immun 2001;69:5121-5130.
9. Song SJ, Pagel CN, Campbell TM, Pike RN, Mackie EJ. The role of protease-activated receptor-1 in bone healing. Am J Pathol 2005;166:857-868.
10. Arayatrakoollikit U, Pavasant P, Yongchaitrakul T. Thrombin induces osteoprotegerin synthesis via phosphatidylinositol 39-kinase/mammalian target of rapamycin pathway in human periodontal ligament cells. J Periodontal Res 2008;43:537-543.
11. Ohuchi N, Hayashi K, Iwamoto K, et al. Thrombinstimulated proliferation is mediated by endothelin-1 in cultured rat gingival fibroblasts. Fundam Clin Pharmacol 2010;24:501-508.
12. Garlet GP, Cardoso CR, Campanelli AP, Martins W Jr., Silva JS. Expression of suppressors of cytokine signaling in diseased periodontal tissues: A stop signal for disease progression? J Periodontal Res 2006;41:580-584.
13. Graves DT, Li J, Cochran DL. Inflammation and uncoupling as mechanisms of periodontal bone loss. J Dent Res 2011;90:143-153.
14. Johnson RB, Serio FG. Leptin within healthy and diseased human gingiva. J Periodontol 2001;72: 1254-1257.
15. Suthin K, Matsushita K, Machigashira M, et al. Enhanced expression of vascular endothelial growth factor by periodontal pathogens in gingival fibroblasts. J Periodontal Res 2003;38:90-96.
16. Unlü F, Güneri PG, Hekimgil M, Yesxilbek B, Boyacioǧlu H. Expression of vascular endothelial growth factor in human periodontal tissues: Comparison of healthy and diabetic patients. J Periodontol 2003;74:181-187.
17. Artese L, Piattelli A, de Gouveia Cardoso LA, et al. Immunoexpression of angiogenesis, nitric oxide synthase, and proliferation markers in gingival samples of patients with aggressive and chronic periodontitis. J Periodontol 2010;81:718-726.
18. American Academy of Periodontology. Glossary of Periodontal Terms, 4th ed. Chicago: American Academy of Periodontology; 2001:24.
19. Cetinkaya BO, Keles GC, Ayas B, Sakallioglu EE, Acikgoz G. The expression of vascular endothelial growth factor in a rat model at destruction and healing stages of periodontal disease. J Periodontol 2007;78:1129-1135.
20. Sakallioǧlu EE, Aliyev E, Lütfioǧlu M, Yavuz U, Acxikgöz G. Vascular endothelial growth factor (VEGF) levels of gingiva and gingival crevicular fluid in diabetic and systemically healthy periodontitis patients. Clin Oral Investig 2007;11:115-120.
21. Spolidorio LC, Herrera BS, Coimbra LS, Figueiredo MN, Spolidorio DM, MuscaráMN. Short-term induction of thrombocytopenia delays periodontal healing in rats with periodontal disease: Participation of endostatin and vascular endothelial growth factor. J Periodontal Res 2010;45:184-192.
22. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. Osteoarthritis Cartilage 2012;20:256-260.
23. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206-209.
24. Cetinkaya BO, Acikgoz G, Ayas B, Aliyev E, Sakallioglu EE. Increased expression of vascular endothelial growth factor in cyclosporin A-induced gingival overgrowth in rats. J Periodontol 2006;77:54-60.
25. Holzhausen M, Rossa Júnior C, Marcantonio Júnior E, Nassar PO, Spolidório DM, Spolidório LC. Effect of selective cyclooxygenase-2 inhibition on the development of ligature-induced periodontitis in rats. J Periodontol 2002;73:1030-1036.
26. Graves DT, Kang J, Andriankaja O, Wada K, Rossa C Jr. Animal models to study host-bacteria interactions involved in periodontitis. Front Oral Biol 2012;15: 117-132.
27. Coimbra LS, Rossa C Jr., Guimarães MR, et al. Influence of antiplatelet drugs in the pathogenesis of experimental periodontitis and periodontal repair in rats. J Periodontol 2011;82:767-777.
28. Duncan MB, Kalluri R. Parstatin, a novel proteaseactivated receptor 1-derived inhibitor of angiogenesis. Mol Interv 2009;9:168-170.
29. Chambers RC, Leoni P, Blanc-Brude OP, Wembridge DE, Laurent GJ. Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. J Biol Chem 2000;275:35584-35591.
30. Ma L, Perini R, McKnight W, et al. Proteinaseactivated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets. Proc Natl Acad Sci USA 2005;102:216-220.